Left Ventricular Diameter and Risk Stratification for Sudden Cardiac Death

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2014 Sep 18

PMID 25227407

Citations 46

Authors

Kumar Narayanan

Kyndaron Reinier

Carmen Teodorescu

Audrey Uy-Evanado

Ryan Aleong

Harpriya Chugh

Gregory A Nichols

Karen Gunson

Barry London

Jonathan Jui

Sumeet S Chugh

Affiliations

Soon will be listed here.

Abstract

Background: Left ventricular (LV) diameter is routinely measured on the echocardiogram but has not been jointly evaluated with the ejection fraction (EF) for risk stratification of sudden cardiac death (SCD).

Methods And Results: From a large ongoing community-based study of SCD (The Oregon Sudden Unexpected Death Study; population ≈1 million), SCD cases were compared with geographic controls. LVEF and LV diameter, measured using the LV internal dimension in diastole (categorized as normal, mild, moderate, or severe dilatation using American Society of Echocardiography definitions) were assessed from echocardiograms prior but unrelated to the SCD event. Cases (n=418; 69.5±13.8 years), compared with controls (n=329; 67.7±11.9 years), more commonly had severe LV dysfunction (EF ≤35%; 30.5% versus 18.8%; P<0.01) and larger LV diameter (52.2±10.5 mm versus 49.7±7.9 mm; P<0.01). Moderate or severe LV dilatation (16.3% versus 8.2%; P=0.001) and severe LV dilatation (8.1% versus 2.1%; P<0.001) were significantly more frequent in cases. In multivariable analysis, severe LV dilatation was an independent predictor of SCD (odds ratio 2.5 [95% CI 1.03 to 5.9]; P=0.04). In addition, subjects with both EF ≤35% and severe LV dilatation had higher odds for SCD compared with those with low EF only (odds ratio 3.8 [95% CI 1.5 to 10.2] for both versus 1.7 [95% CI 1.2 to 2.5] for low EF only), suggesting that severe LV dilatation additively increased SCD risk.

Conclusion: LV diameter may contribute to risk stratification for SCD independent of the LVEF. This readily available echocardiographic measure warrants further prospective evaluation.

Citing Articles

Cardiac CT in Large Vessel Occlusion Stroke for the Evaluation of Non-Thrombotic and Non-Atrial-Fibrillation-Related Embolic Causes.

Mostafa K, Wunsche C, Krutmann S, Wolf C, Aludin S, Larsen N Neurol Int. 2025; 17(2).

PMID: 39997656 PMC: 11858386. DOI: 10.3390/neurolint17020025.

Observational study of sudden cardiac arrest risk (OSCAR): Rationale and design of an electronic health records cohort.

Reinier K, Chugh H, Uy-Evanado A, Heckard E, Mathias M, Bosson N Int J Cardiol Heart Vasc. 2025; 56:101614.

PMID: 39897418 PMC: 11787554. DOI: 10.1016/j.ijcha.2025.101614.

Is elabela/toddler a poor prognostic marker in heart failure patients?.

Kucuk U, Kirilmaz B, Kaya H, Aksit E, Arslan K Hippokratia. 2024; 27(4):126-131.

PMID: 39372325 PMC: 11451502.

Unveiling the Mechanism of Protective Effects of Tanshinone as a New Fighter Against Cardiovascular Diseases: A Systematic Review.

Dabbaghi M, Roudi H, Safaei R, Baradaran Rahimi V, Fadaei M, Askari V Cardiovasc Toxicol. 2024; 24(12):1467-1509.

PMID: 39306819 DOI: 10.1007/s12012-024-09921-x.

Shared genetic risk between anorexia nervosa and cardiovascular disease events: Evidence from genome-wide association studies.

Qi B, Graff M, Eating Disorders Working Group Of The Psychiatric Genomics Consortium , Bulik C, North K, Munn-Chernoff M Brain Behav. 2024; 14(2):e3294.

PMID: 38282367 PMC: 10897497. DOI: 10.1002/brb3.3294.

References

Bardy G, Lee K, Mark D, Poole J, Packer D, Boineau R . Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352(3):225-37. DOI: 10.1056/NEJMoa043399. View

Cleland J, Daubert J, Erdmann E, Freemantle N, Gras D, Kappenberger L . The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005; 352(15):1539-49. DOI: 10.1056/NEJMoa050496. View

Zecchin M, Lenarda A, Proclemer A, Faganello G, Facchin D, Petz E . The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy. Europace. 2004; 6(5):400-6. DOI: 10.1016/j.eupc.2004.04.009. View

Yetman A, Bornemeier R, McCrindle B . Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death?. J Am Coll Cardiol. 2003; 41(2):329-32. DOI: 10.1016/s0735-1097(02)02699-2. View

Stecker E, Vickers C, Waltz J, Socoteanu C, John B, Mariani R . Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol. 2006; 47(6):1161-6. DOI: 10.1016/j.jacc.2005.11.045. View

Steinhaus D, Vittinghoff E, Moffatt E, Hart A, Ursell P, Tseng Z . Characteristics of sudden arrhythmic death in a diverse, urban community. Am Heart J. 2011; 163(1):125-31. PMC: 3241924. DOI: 10.1016/j.ahj.2011.09.016. View

Quinones M, GREENBERG B, Kopelen H, Koilpillai C, Limacher M, Shindler D . Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 2000; 35(5):1237-44. DOI: 10.1016/s0735-1097(00)00511-8. View

Moss A, Schuger C, Beck C, Brown M, Cannom D, Daubert J . Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012; 367(24):2275-83. DOI: 10.1056/NEJMoa1211107. View

Thavendiranathan P, Grant A, Negishi T, Plana J, Popovic Z, Marwick T . Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol. 2012; 61(1):77-84. DOI: 10.1016/j.jacc.2012.09.035. View

10.

Solomon S, Foster E, Bourgoun M, Shah A, Viloria E, Brown M . Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy. Circulation. 2010; 122(10):985-92. DOI: 10.1161/CIRCULATIONAHA.110.955039. View

11.

Gorgels A, Van Ree J, Daemen M, Houben L, Wellens H . Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol. 1997; 30(6):1500-5. DOI: 10.1016/s0735-1097(97)00355-0. View

12.

Watanabe J, Shiba N, Shinozaki T, Koseki Y, Karibe A, Komaru T . Prognostic value of plasma brain natriuretic peptide combined with left ventricular dimensions in predicting sudden death of patients with chronic heart failure. J Card Fail. 2005; 11(1):50-5. DOI: 10.1016/j.cardfail.2004.06.434. View

13.

Myerburg R . Implantable cardioverter-defibrillators after myocardial infarction. N Engl J Med. 2008; 359(21):2245-53. DOI: 10.1056/NEJMra0803409. View

14.

Adabag A, Peterson G, Apple F, Titus J, King R, Luepker R . Etiology of sudden death in the community: results of anatomical, metabolic, and genetic evaluation. Am Heart J. 2010; 159(1):33-9. PMC: 2905235. DOI: 10.1016/j.ahj.2009.10.019. View

15.

Lang R, Bierig M, Devereux R, Flachskampf F, Foster E, Pellikka P . Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of.... J Am Soc Echocardiogr. 2005; 18(12):1440-63. DOI: 10.1016/j.echo.2005.10.005. View

16.

Ranade V, Molnar J, Khokher T, Agarwal A, Mosnaim A, Somberg J . Effect of angiotensin-converting enzyme therapy on QT interval dispersion. Am J Ther. 2001; 6(5):257-61. DOI: 10.1097/00045391-199909000-00005. View

17.

Moss A, Zareba W, Hall W, Klein H, Wilber D, Cannom D . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346(12):877-83. DOI: 10.1056/NEJMoa013474. View

18.

Nichol G, Thomas E, Callaway C, Hedges J, Powell J, Aufderheide T . Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA. 2008; 300(12):1423-31. PMC: 3187919. DOI: 10.1001/jama.300.12.1423. View

19.

Lee T, Hamilton M, Stevenson L, Moriguchi J, Fonarow G, Child J . Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol. 1993; 72(9):672-6. DOI: 10.1016/0002-9149(93)90883-e. View

20.

Poole J, Johnson G, Hellkamp A, Anderson J, Callans D, Raitt M . Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008; 359(10):1009-17. PMC: 2922510. DOI: 10.1056/NEJMoa071098. View